Stevanato Group S.p.A STVN Stock
Stevanato Group S.p.A Price Chart
Stevanato Group S.p.A STVN Financial and Trading Overview
| Stevanato Group S.p.A stock price | 20.1 USD |
| Previous Close | 19.65 USD |
| Open | 19.76 USD |
| Bid | 0 USD x 20000 |
| Ask | 20.6 USD x 50000 |
| Day's Range | 19.8 - 20.64 USD |
| 52 Week Range | 12.89 - 28 USD |
| Volume | 373.2K USD |
| Avg. Volume | 362.56K USD |
| Market Cap | 5.49B USD |
| Beta (5Y Monthly) | 0.737 |
| PE Ratio (TTM) | 34.0678 |
| EPS (TTM) | 0.59 USD |
| Forward Dividend & Yield | 0.06 (0.29%) |
| Ex-Dividend Date | June 11, 2026 |
| 1y Target Est | 24.45 USD |
STVN Valuation Measures
| Enterprise Value | 5.96B USD |
| Trailing P/E | 34.0678 |
| Forward P/E | 24.050829 |
| PEG Ratio (5 yr expected) | 3.57 |
| Price/Sales (ttm) | 4.5624685 |
| Price/Book (mrq) | 3.146166 |
| Enterprise Value/Revenue | 4.953 |
| Enterprise Value/EBITDA | 20.651 |
Trading Information
Stevanato Group S.p.A Stock Price History
| Beta (5Y Monthly) | 0.737 |
| 52-Week Change | -14.38% |
| S&P500 52-Week Change | 19.78% |
| 52 Week High | 28 USD |
| 52 Week Low | 12.89 USD |
| 50-Day Moving Average | 18.62 USD |
| 200-Day Moving Average | 18.74 USD |
STVN Share Statistics
| Avg. Volume (3 month) | 362.56K USD |
| Avg. Daily Volume (10-Days) | 365.93K USD |
| Shares Outstanding | 49.83M |
| Float | 48.9M |
| Short Ratio | 2.89 |
| % Held by Insiders | 1.65% |
| % Held by Institutions | 96.07% |
| Shares Short | 966.43K |
| Short % of Float | 1.96% |
| Short % of Shares Outstanding | 0.34% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.105900005 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 11.74% |
| Operating Margin (ttm) | 14.24% |
| Gross Margin | 29.21% |
| EBITDA Margin | 23.98% |
Management Effectiveness
| Return on Assets (ttm) | 5.27% |
| Return on Equity (ttm) | 9.59% |
Income Statement
| Revenue (ttm) | 1.2B USD |
| Revenue Per Share (ttm) | 4.41 USD |
| Quarterly Revenue Growth (yoy) | 6.60% |
| Gross Profit (ttm) | 351.58M USD |
| EBITDA | 288.58M USD |
| Net Income Avi to Common (ttm) | 141.35M USD |
| Diluted EPS (ttm) | 0.59 |
| Quarterly Earnings Growth (yoy) | 5.70% |
Balance Sheet
| Total Cash (mrq) | 112.28M USD |
| Total Cash Per Share (mrq) | 0.41 USD |
| Total Debt (mrq) | 450.58M USD |
| Total Debt/Equity (mrq) | 29.43 USD |
| Current Ratio (mrq) | 1.632 |
| Book Value Per Share (mrq) | 6.388728 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 261.73M USD |
| Levered Free Cash Flow (ttm) | -57059124 USD |
Profile of Stevanato Group S.p.A
| Country | United States |
| State | PD |
| City | Piombino Dese |
| Address | Via Molinella 17 |
| ZIP | 35017 |
| Phone | 39 04 99 31 811 |
| Website | https://www.stevanatogroup.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 6010 |
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Q&A For Stevanato Group S.p.A Stock
What is a current STVN stock price?
Stevanato Group S.p.A STVN stock price today per share is 20.1 USD.
How to purchase Stevanato Group S.p.A stock?
You can buy STVN shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stevanato Group S.p.A?
The stock symbol or ticker of Stevanato Group S.p.A is STVN.
Which industry does the Stevanato Group S.p.A company belong to?
The Stevanato Group S.p.A industry is Medical Instruments & Supplies.
How many shares does Stevanato Group S.p.A have in circulation?
The max supply of Stevanato Group S.p.A shares is 273.13M.
What is Stevanato Group S.p.A Price to Earnings Ratio (PE Ratio)?
Stevanato Group S.p.A PE Ratio is 34.06780000 now.
What was Stevanato Group S.p.A earnings per share over the trailing 12 months (TTM)?
Stevanato Group S.p.A EPS is 0.59 USD over the trailing 12 months.
Which sector does the Stevanato Group S.p.A company belong to?
The Stevanato Group S.p.A sector is Healthcare.
Stevanato Group S.p.A STVN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index
NYA
US
|
24513.81 USD — |
+0.21
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}
